Breath of Health, an Israel-based healthcare technology company, is beginning clinical studies of its proprietary breath-based technology for the early detection of cancer. The company, founded in 2020, has been developing quick and accurate breath-based diagnostics for early life-saving detection of cancer, Alzheimer’s, and other diseases. Their mission is to improve existing cancer screening programs through the widespread adoption of their proven disease detection method.
Utilizing AI to detect a broad range of cancerous biomarkers, Breath of Health aims to provide a non-invasive screening platform to save lives. Through molecular analysis, the technology can detect early responses in the immune system, even in asymptomatic stages. The company focused initially on lung cancer before the research was delayed due to the COVID-19 pandemic. However, with pre-approval from European regulators, their internationally patented algorithm can accurately diagnose COVID-19. According to the company, one of the major advantages of its disease detection system is its affordable testing. This aims at democratizing access to early cancer detection options and improving healthcare technology for everyone.
The company regained momentum with its research on cancer detection after the height of the Covid pandemic. They started by focusing on lung cancer and then continued their effort further with prostate cancer, breast cancer, bladder cancer, colorectal cancer, and more. According to the company, their technology achieved significant results in colorectal cancer, predicting 97% of cases with positive results of at least polyp up to cancer. They plan to start clinical studies in the US for breast cancer in May.
The technology can detect with 100% accuracy, based on clinical studies in Israel Adenocarcinoma in prostate cancer. It can also identify pre-cancerous conditions such as DCIS, and eventually, subtypes of breast cancer, allowing for more frequent screening at a lower cost. The breath-based test provided by the company costs between $10 to $15, compared to mammography, which costs between $200 to $300. In addition, this method eliminates the risk of exposure to radiation.
The breath sample is collected in an aluminum bag, then processed by reducing the temperature to minus 20 degrees Celsius for at least three minutes, eliminating approximately 80% of the liquids. The bag is then processed using their aerosol generator, which generates droplets of 5 to 15 microns that go through the optical gas cell. The original detection is 200 parts per billion, but the company has managed to reduce it to one part per trillion.
Breath of Health is motivated by humanitarian considerations and the desire to save lives, especially women diagnosed with breast cancer. The company’s technology can detect breast cancer early, leading to more favorable health outcomes for patients, with detection at stage two leading to 99% of 5 years survival.
Breath of Health’s machine is a standalone system and requires only electricity to perform it’s analysis of breath and delivery of results, meaning it’s services can be of great benefit to those in remote areas without access to hospitals with Mammography wings.
"We are not motivated by monetary benefits. The technology is inspired by Breath of Health’s focus on humanity. Our technology is capable of detecting breast cancer at an early stage, which can lead to considerable life-saving benefits. We believe that the breath-based technology for early detection of cancer is a significant breakthrough in healthcare. With its non-invasive screening platform and low-cost testing, we aim to improve existing cancer screening programs and save lives”, says Arie Laor, Founder of Breath of Health.
Media contact:
Name: Arie Laor
Email: ariel@bohpharma.com
Published by: Omar Hamdi